Superworth

Prime Medicine market cap PRME

Share price times shares outstanding: what the whole company sells for, since 2022.

Today, Nov 2, 2026
$805.3M
Highest close in our data
$2.1B
Feb 2023

Prime Medicine is worth $805.3M at the close on Nov 2, 2026, at $4.44 a share.

That is up 17% over the last year.

Its highest close in our data was $2.1B in Feb 2023.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$805.3M$502.1M$856.1M+27%
2025$631.8M$154.9M$850.5M+66%
2024$380.4M$377.7M$1B−56%
2023$862.3M$543.9M$2.1B−52%
2022$1.8B$1.6B$2Bn/a

Against its peers

Companies in Biotechnology nearest Prime Medicine's size, closest first, today.

CompanyMarket cap
PRMEPrime Medicine$805.3M
MGTXMeiraGTx$895.1M
VCELVericel$2.1B
ADMAAdma Biologics$2.5B
PLXProtalix BioTherapeutics$206.3M
Peer median$1.5B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Prime Medicine

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.